| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-resistant + 355/08) |
- |
- |
5 － ? |
Ag (nanoparticles suspension H)  |
936 |
| Staphylococcus aureus (methicillin-resistant + 356/08) |
- |
- |
10 － ? |
Ag (nanoparticles suspension H) |
936 |
| Staphylococcus aureus (methicillin-resistant + 357/08) |
- |
- |
10 － ? |
Ag (nanoparticles suspension H) |
936 |
| Staphylococcus aureus (methicillin-resistant + 376/08) |
- |
- |
10 － ? |
Ag (nanoparticles suspension H) |
936 |
| Staphylococcus aureus (methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
2 |
8 |
1 － 16 |
Cefquinome |
1486 |
| Staphylococcus aureus (methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
2 |
8 |
1 － 32 |
Cefpirome |
1486 |
| Staphylococcus aureus (methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
4 |
32 |
2 － >64 |
Cefepime (Maxipime) |
1486 |
| Staphylococcus aureus (methicillin-resistant + ampicillin-resistant + cefazolin-resistant) |
16 |
64 |
16 － >64 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1486 |
| Staphylococcus aureus (methicillin-resistant + ATCC 700698) |
- |
- |
100 － ? |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
1499 |
| Staphylococcus aureus (methicillin-resistant + CAMHB + 25% bovine serum) |
8 |
8 |
4 － 8 |
Targocil |
1276 |
| Staphylococcus aureus (methicillin-resistant + CAMHB + 25% bovine serum) |
>32 |
>32 |
>32 － ? |
1835F03 |
1276 |
| Staphylococcus aureus (methicillin-resistant + CAMHB) |
>8 |
>32 |
4 － >32 |
1835F03 |
1276 |
| Staphylococcus aureus (methicillin-resistant + chicken isolate) |
- |
- |
50 － ? |
Kanamycin A |
1499 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-resistant) |
16 |
32 |
2 － 64 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-resistant) |
>32 |
>32 |
4 － >32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-resistant) |
>32 |
>32 |
12 － >32 |
Ceftriaxone (Rocephin) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-resistant) |
>64 |
>256 |
2 － >256 |
Zosyn |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
≤0.06 |
≤0.06 |
≤0.06 － 0.5 |
Trovafloxacin (Trovan) |
21 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
0.5 |
1 |
0.25 － 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
1 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
21 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
8 |
16 |
0.5 － 32 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
8 |
64 |
1 － >256 |
Zosyn |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
>- |
>32 |
2 － >32 |
Ceftriaxone (Rocephin) |
102 |
| Staphylococcus aureus (methicillin-resistant + ciprofloxacin-susceptible) |
- |
- |
0.12 － 2 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
21 |
| Staphylococcus aureus (methicillin-resistant + clinical isolate) |
- |
- |
32 － ? |
RRP9W4N |
1361 |
| Staphylococcus aureus (methicillin-resistant + community-acquired) |
1 |
1 |
1 － ? |
Vancomycin (Vancocyn, Lyphocin) |
189 |
| Staphylococcus aureus (methicillin-resistant + community-acquired) |
32 |
32 |
16 － 32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
189 |
| Staphylococcus aureus (methicillin-resistant + fluoroquinolone-resistant) |
0.06 |
0.25 |
0.03 － 0.5 |
ACH-702 |
1279 |